Zynex - Stock Split History | ZYXI

Stock split history for Zynex since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Zynex Annual Stock Splits
Zynex Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.251B $0.032B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33